1. Emery P. Selective COX-2 inhibition: relevance in arthritis. Curr Opin Rheumatol;8(suppl 1):S21–4. 1996
2. Fries J. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol;18:6–10. 1991
3. Fries J, Miller SR, Spitz PW, et al. Toward and epidemiology of gastropathy associated with non-steroidal anti-inflammatory drugs use. Gastroenterol;96:647–55. 1989
4. Myllykangas-Luosujarvi R, Aho K, Isomäki H. Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol;22:2214–7. 1995
5. Collier D St J, Pain JA. Anti-inflammatory drugs and upper gastrointestinal perforation. In: Rainsford KD, Velo GP, eds. Side effects of anti-inflammatory drugs, part 1: clinical and epidemiological aspects. Lancaster: MTP Press:285–93. 1986